Citation Impact
Citing Papers
In vivo Optical Molecular Imaging of Vascular Endothelial Growth Factor for Monitoring Cancer Treatment
2008
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
2004
Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature
2006
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
The regulation of IL-10 production by immune cells
2010 Standout
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
2006 Standout
Cytokines in inflammatory bowel disease
2014 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Colitis-associated cancer: the role of T cells in tumor development
2009
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients
2004
Toll-Like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer
2010
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Lung Cancer
2008 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Coordinated regulation of myeloid cells by tumours
2012 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Use of a Cytokine Gene Expression Signature in Lung Adenocarcinoma and the Surrounding Tissue as a Prognostic Classifier
2007
Hepatitis C virus and microRNAs: miRed in a host of possibilities
2014
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Role of the gut microbiota in immunity and inflammatory disease
2013 Standout
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
2005 Standout
Regulatory T cells, tumour immunity and immunotherapy
2006 Standout
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Interleukin-6 - A Key Regulator of Colorectal Cancer Development
2012
Strategies for use of IL‐10 or its antagonists in human disease
2008
Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells
2009
Immunity, Inflammation, and Cancer
2010 Standout
Electrochemical immunosensors for interleukin-6. Comparison of carbon nanotube forest and gold nanoparticle platforms
2009
Regulatory T cells in cancer immunotherapy
2016 StandoutNobel
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction
2005
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
2008 Standout
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
Interleukin‐10 promotes B16‐melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation
2002
Activation-Induced Cytidine Deaminase Expression in CD4+ T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age
2011 StandoutNobel
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Colorectal cancer
2005
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Regulatory T cells in tumor immunity
2010 StandoutNobel
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Cancer and the chemokine network
2004 Standout
Interleukin‐6 and its receptor in cancer
2007
Tight Glycemic Control Reduces Heart Inflammation and Remodeling During Acute Myocardial Infarction in Hyperglycemic Patients
2009
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
2002 Standout
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Alternative activation of macrophages
2003 Standout
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
2005
CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies
2003
Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
2009
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells
2004 StandoutNobel
Anti‐IL ‐6 receptor mA b eliminates myeloid‐derived suppressor cells and inhibits tumor growth by enhancing T ‐cell responses
2012
Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer.
2005
Regulatory T Cells and Human Disease
2020 StandoutNobel
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
RANTES expression is a predictor of survival in stage I lung adenocarcinoma.
2002
Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer
2005
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Ammonium Trichloro(dioxoethylene-o,o′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop
2004
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Dual Roles for Immunity in Gastrointestinal Cancers
2010
Works of Ciro Romano being referenced
Interleukin-6 Serum Level Correlates with Survival in Advanced Gastrointestinal Cancer Patients but Is Not an Independent Prognostic Indicator
2001
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival
2000
Prognostic Significance of Circulating IL-10 and IL-6 Serum Levels in Colon Cancer Patients Undergoing Surgery
2002
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations
2013
Serum Interleukin-10 Levels as a Prognostic Factor in Advanced Non-small Cell Lung Cancer Patients
2000
Determination of Molecular Marker Expression Can Predict Clinical Outcome in Colon Carcinomas
2004
Effects of Stress Hyperglycemia on Acute Myocardial Infarction
2003
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors.
2000
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies
1999